Day after day, the noble goals and lofty goals of Saudi Vision 2030 are being revealed, especially in terms of their repercussions on the quality of life of the Saudi person. Among that is what Okaz publishes today about the details of the draft regulation for the transformation of the health sector, whose main objective is to provide the best quality health care for people, citizens and residents. The regulation also resolves medical issues that raise controversy everywhere in the world, such as the desire to abort fetuses, removing artificial respirators and resuscitating patients who do not hope for recovery. It includes clear texts and strict penalties for health practitioners who violate the regulations, including that some of them promote their services in a manner that violates the ethics of the medical profession, and some of them obtain rewards or incentives from pharmaceutical companies and health institutions, so he instructs his patients to take their medicines from a pharmacy that he determines for them, or to conduct analyzes in a laboratory of his choice. . Also, one of the biggest gains included in the draft is aiding emergency health cases without financial compensation. It is an achievement that represents the pinnacle of humanity, and respect for the human right to treatment. The noble goals of Vision 2030 are not limited to the health sector, as they include all aspects of the economy and social life. And by 2030, its biggest goal will be achieved, which is to liberate the Saudi economy from the bondage of dependence on oil revenues alone.
Read next
Regulatory Bodies Tighten Approval Frameworks for AI Diagnostic Tools
Health authorities are introducing post-market surveillance mandates for algorithmic diagnostic software to track real-world clinical accuracy and drift.
GLP-1 Class Drugs Reshape Pharmaceuticals and Healthcare Sector Valuations
The rapid adoption of GLP-1 receptor agonists is impacting corporate health strategies, insurance coverage models, and adjunctive medical…
Inflammation: What It Is and What the Word Is Doing in Marketing
A genuine biological process, and a word attached to a great many products that do not affect it.
Enterprise Adoption of AI Diagnostics Faces Integration Bottlenecks
Healthcare providers are struggling to scale artificial intelligence diagnostic tools due to legacy EHR interoperability issues and stringent…
GLP-1 Class Drugs Reshape Commercial Pharmaceutical Supply Chains and R&D Focus
Surging demand for metabolic therapies forces pharmaceutical manufacturers to reallocate capital toward fill-finish capacity and specialized supply networks.
The Weight-Loss Drugs Changed More Than Waistlines
A class of drugs originally for diabetes reshaped obesity treatment and several industries around it.